-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News, June 8th.
At present, the national centralized procurement has conducted four batches and five rounds.
As the results of the previous rounds of centralized procurement have been implemented in various places, the medical insurance supporting policies have been promulgated and implemented accordingly
.
Among them, the retention of medical insurance balances is also the focus of the industry
.
At present, the national centralized procurement has conducted four batches and five rounds.
As the results of the previous rounds of centralized procurement have been implemented in various places, the medical insurance supporting policies have been promulgated and implemented accordingly
.
Among them, the retention of medical insurance balances is also the focus of the industry
.
On June 4, the Guangxi Autonomous Region Medical Insurance Bureau and the Autonomous Region’s Department of Finance issued the "Implementation Opinions on the Retention of Chinese Medical Insurance Funds for the Centralized Purchase of Drugs by the State and the Autonomous Region
.
"
.
"
This opinion applies to all batches of centralized procurement drug varieties organized by the state, inter-provincial alliances, and autonomous regions
.
According to the agreed procurement volume and the selected price of the selected products of the centralized procurement agency, the amount of the non-selected products used, as well as the actual payment ratio of the medical insurance fund in the overall planning area and the proportion of the insured patients in the centralized procurement of generic drugs, the calculation of the centralized procurement agency The amount of medical insurance expenditures for generic drugs that are lower than the part of the medical insurance fund budget for centralized drugs is the base for calculating the balance
.
.
According to the agreed procurement volume and the selected price of the selected products of the centralized procurement agency, the amount of the non-selected products used, as well as the actual payment ratio of the medical insurance fund in the overall planning area and the proportion of the insured patients in the centralized procurement of generic drugs, the calculation of the centralized procurement agency The amount of medical insurance expenditures for generic drugs that are lower than the part of the medical insurance fund budget for centralized drugs is the base for calculating the balance
.
The opinion also pointed out that other medical procurement work in the whole district can refer to this implementation opinion and implement the retention of medical insurance funds
.
All centralized procurement agencies must do a good job in the smooth replacement of selected products, precise policy implementation, and no “one size fits all”
.
.
All centralized procurement agencies must do a good job in the smooth replacement of selected products, precise policy implementation, and no “one size fits all”
.
The policy of "Medical Reserve and Surplus Balance" has changed, and it must not be directly linked to departments and individuals!
Just in April this year, a "Notice on Strengthening the Management of the Use of the Balance of Medical Insurance Funds for the Centralized Procurement of Medicines and Consumables in the State Organization" was circulated in the industry
.
It pointed out that medical institutions should make good use of the increased disposable income by reducing the cost of medicines and consumables, implement the "two permits" requirements, actively promote the reform of the salary system, mobilize the enthusiasm of medical staff, and must not directly use the remaining funds for centralized procurement of medical insurance.
Departments and personal incentives are linked
.
.
It pointed out that medical institutions should make good use of the increased disposable income by reducing the cost of medicines and consumables, implement the "two permits" requirements, actively promote the reform of the salary system, mobilize the enthusiasm of medical staff, and must not directly use the remaining funds for centralized procurement of medical insurance.
Departments and personal incentives are linked
.
Note that some changes have taken place in the incentive methods and targets of surplus funds, and it has been clarified that surplus funds should not be linked to the use of departments and personal incentives
.
The precise description of the prohibited scope is obviously an optimization of the previous policy to prevent certain departments and individuals from prescribing random prescriptions in order to get bonus incentives
.
This provision is consistent with the "Nine Prohibitions"-the prohibition of linking the personal income of medical and health personnel with the income of medicines and medical examinations, and the prohibition of issuing commissions
.
.
The precise description of the prohibited scope is obviously an optimization of the previous policy to prevent certain departments and individuals from prescribing random prescriptions in order to get bonus incentives
.
This provision is consistent with the "Nine Prohibitions"-the prohibition of linking the personal income of medical and health personnel with the income of medicines and medical examinations, and the prohibition of issuing commissions
.
If you compare the above regulations with the chain pharmacy 's rebate policy for manufacturers, it is found that there is the same truth
.
Chain pharmacies generally taboo that manufacturers directly reward the store manager and clerk.
Instead, they require manufacturers to return the rebates to the chain headquarters, which has its own set of internal incentive measures
.
This is to prevent some manufacturers' rebates from wooing their own shop assistants and prevent them from becoming the factory's promoters
.
.
Chain pharmacies generally taboo that manufacturers directly reward the store manager and clerk.
Instead, they require manufacturers to return the rebates to the chain headquarters, which has its own set of internal incentive measures
.
This is to prevent some manufacturers' rebates from wooing their own shop assistants and prevent them from becoming the factory's promoters
.
The attitude reflected in the optimization of the content of this circulating version of the document is also to prevent certain risks from occurring.
Therefore, some pharmaceutical companies use the surplus reserve policy to accelerate the over-completed procurement of selected products , and may face some new changes
.
Therefore, some pharmaceutical companies use the surplus reserve policy to accelerate the over-completed procurement of selected products , and may face some new changes
.
In June last year, the National Medical Insurance Administration and the Ministry of Finance jointly issued the "Guiding Opinions on the Retention of Chinese Medical Insurance Funds for Centralized Drug Purchase by the State", which was formulated on the basis of three rounds and two batches of the National Mass Purchase (VBP) operation.
Supporting documents for medical insurance
.
Supporting documents for medical insurance
.
The core idea of the opinion is “reserve the balance”, that is, the difference between the drug cost after the VBP price reduction and the budget fund paid by the medical insurance will be returned as a part of the reward to the public medical institution, which will greatly stimulate the medical institution to give priority to using the selected product, and has an even more impact The future trend of non-selected varieties
.
.
Some provinces and cities have cashed out the remaining funds for medical insurance
Since then, various provinces and cities have successively issued documents to clarify the relevant policies for the retention of balances
.
So, as for the results of various medical institutions after implementation, we have also collected relevant data
.
.
So, as for the results of various medical institutions after implementation, we have also collected relevant data
.
On December 4, 2020, the Hunan Provincial Medical Insurance Bureau issued the "Implementation Opinions on the Retention of the Chinese Medical Insurance Funds in the Centralized Procurement of Drugs Organized by the State (for Trial Implementation)"
.
.
On January 15 this year, according to the "Chongqing Daily" report, a total of 157 medical institutions in Chongqing participated in the first batch of national centralized procurement of 25 selected drugs and medical insurance fund balance retention assessment, of which 102 medical institutions passed the assessment and the balance medical insurance fund was 61,974,400 Yuan
.
.
In December last year, according to a report by Great Wall.
com, the Hebei Provincial Medical Security Bureau and the Hebei Provincial Department of Finance passed a joint assessment and assessment, combined with the self-evaluation of the Hebei Provincial People’s Hospital and other 26 medical institutions participating in the first batch of centralized drug procurement, and allocated the balance.
More than 8.
47 million yuan was retained, and the payment was completed on November 5, 2020
.
com, the Hebei Provincial Medical Security Bureau and the Hebei Provincial Department of Finance passed a joint assessment and assessment, combined with the self-evaluation of the Hebei Provincial People’s Hospital and other 26 medical institutions participating in the first batch of centralized drug procurement, and allocated the balance.
More than 8.
47 million yuan was retained, and the payment was completed on November 5, 2020
.
According to the news from the "Xiamen Haixi Medical Trading Center" in November 2020, Haixi has helped many cities in Hebei Province, such as Handan, Hengshui, Xinji, Dingzhou, and Qinhuangdao, complete the calculation of remaining balances.
The amount of remaining funds that can be allocated to medical institutions exceeds hundreds of millions of yuan
.
The amount of remaining funds that can be allocated to medical institutions exceeds hundreds of millions of yuan
.
Among them, the calculation scope of Handan City's remaining balance is the first batch of 25 countries to purchase medicines, 370 medical institutions are reported in the city, and a total of 281 hospitals have generated remaining balances
.
According to preliminary calculations, the estimated base of the city's first batch of national organizations with drug balances is about 100 million yuan.
According to the largest balance retention ratio of 50%, the balance retained for return to medical institutions this time is about 51,816,800 yuan
.
.
According to preliminary calculations, the estimated base of the city's first batch of national organizations with drug balances is about 100 million yuan.
According to the largest balance retention ratio of 50%, the balance retained for return to medical institutions this time is about 51,816,800 yuan
.
The space for non-selected varieties is getting smaller and smaller, how should pharmaceutical companies respond?
Regarding the definition and calculation formula analysis of the medical insurance balance retention policy, we also wrote an article "The Outflow of Medical Insurance "Retention Balance" Policy, Analysis of 3 Core Indicators", which can be accessed by clicking the blue title
.
.
Among them, it is worth noting that although the relevant policy does not clearly state that the non-selected products are not allowed to be used, there is still room for it.
After all, the non-selected and the selected varieties are in the hospital drug catalog, and the use of the selected varieties has priority and evaluation indicators.
, Also retains the right to choose non-selected varieties
.
However, the right of choice is obviously not advantageous to priority, and its purpose is to force relevant pharmaceutical companies to actively participate in centralized procurement
.
After all, the non-selected and the selected varieties are in the hospital drug catalog, and the use of the selected varieties has priority and evaluation indicators.
, Also retains the right to choose non-selected varieties
.
However, the right of choice is obviously not advantageous to priority, and its purpose is to force relevant pharmaceutical companies to actively participate in centralized procurement
.
In addition, some experts analyzed that the amount of use of non-selected products will be accumulated in the retention of medical insurance balances, which reduces incentives.
It is very detrimental to products with excessive price reductions.
The purpose of this policy is to encourage accurate reporting of localities and encourage various Hospitals use as many selected products as possible
.
It is very detrimental to products with excessive price reductions.
The purpose of this policy is to encourage accurate reporting of localities and encourage various Hospitals use as many selected products as possible
.
It can be predicted that in the future, under the dual effects of the continuous lowering of drug prices with volume purchases and the retention of medical insurance balances, medical institutions will mainly adopt selected drugs , which indirectly suppresses the use of non-selected products.
For non-selected drugs, more and more room for survival The smaller the size, the related pharmaceutical companies will also be affected to a certain extent
.
For non-selected drugs, more and more room for survival The smaller the size, the related pharmaceutical companies will also be affected to a certain extent
.
Medical Network News, June 8th.
At present, the national centralized procurement has conducted four batches and five rounds.
As the results of the previous rounds of centralized procurement have been implemented in various places, the medical insurance supporting policies have been promulgated and implemented accordingly
.
Among them, the retention of medical insurance balances is also the focus of the industry
.
At present, the national centralized procurement has conducted four batches and five rounds.
As the results of the previous rounds of centralized procurement have been implemented in various places, the medical insurance supporting policies have been promulgated and implemented accordingly
.
Among them, the retention of medical insurance balances is also the focus of the industry
.
On June 4, the Guangxi Autonomous Region Medical Insurance Bureau and the Autonomous Region’s Department of Finance issued the "Implementation Opinions on the Retention of Chinese Medical Insurance Funds for the Centralized Purchase of Drugs by the State and the Autonomous Region
.
"
.
"
This opinion applies to all batches of centralized procurement drug varieties organized by the state, inter-provincial alliances, and autonomous regions
.
According to the agreed procurement volume and the selected price of the selected products of the centralized procurement agency, the amount of the non-selected products used, as well as the actual payment ratio of the medical insurance fund in the overall planning area and the proportion of the insured patients in the centralized procurement of generic drugs, the calculation of the centralized procurement agency The amount of medical insurance expenditures for generic drugs that are lower than the part of the medical insurance fund budget for centralized drugs is the base for calculating the balance
.
.
According to the agreed procurement volume and the selected price of the selected products of the centralized procurement agency, the amount of the non-selected products used, as well as the actual payment ratio of the medical insurance fund in the overall planning area and the proportion of the insured patients in the centralized procurement of generic drugs, the calculation of the centralized procurement agency The amount of medical insurance expenditures for generic drugs that are lower than the part of the medical insurance fund budget for centralized drugs is the base for calculating the balance
.
The opinion also pointed out that other medical procurement work in the whole district can refer to this implementation opinion and implement the retention of medical insurance funds
.
All centralized procurement agencies must do a good job in the smooth replacement of selected products, precise policy implementation, and no “one size fits all”
.
.
All centralized procurement agencies must do a good job in the smooth replacement of selected products, precise policy implementation, and no “one size fits all”
.
The policy of "Medical Reserve and Surplus Balance" has changed, and it must not be directly linked to departments and individuals!
Just in April this year, a "Notice on Strengthening the Management of the Use of the Balance of Medical Insurance Funds for the Centralized Procurement of Medicines and Consumables in the State Organization" was circulated in the industry
.
It pointed out that medical institutions should make good use of the increased disposable income by reducing the cost of medicines and consumables, implement the "two permits" requirements, actively promote the reform of the salary system, mobilize the enthusiasm of medical staff, and must not directly use the remaining funds for centralized procurement of medical insurance.
Departments and personal incentives are linked
.
.
It pointed out that medical institutions should make good use of the increased disposable income by reducing the cost of medicines and consumables, implement the "two permits" requirements, actively promote the reform of the salary system, mobilize the enthusiasm of medical staff, and must not directly use the remaining funds for centralized procurement of medical insurance.
Departments and personal incentives are linked
.
Note that some changes have taken place in the incentive methods and targets of surplus funds, and it has been clarified that surplus funds should not be linked to the use of departments and personal incentives
.
The precise description of the prohibited scope is obviously an optimization of the previous policy to prevent certain departments and individuals from prescribing random prescriptions in order to get bonus incentives
.
This provision is consistent with the "Nine Prohibitions"-the prohibition of linking the personal income of medical and health personnel with the income of medicines and medical examinations, and the prohibition of issuing commissions
.
.
The precise description of the prohibited scope is obviously an optimization of the previous policy to prevent certain departments and individuals from prescribing random prescriptions in order to get bonus incentives
.
This provision is consistent with the "Nine Prohibitions"-the prohibition of linking the personal income of medical and health personnel with the income of medicines and medical examinations, and the prohibition of issuing commissions
.
If you compare the above regulations with the chain pharmacy 's rebate policy for manufacturers, it is found that there is the same truth
.
Chain pharmacies generally taboo that manufacturers directly reward the store manager and clerk.
Instead, they require manufacturers to return the rebates to the chain headquarters, which has its own set of internal incentive measures
.
This is to prevent some manufacturers' rebates from wooing their own shop assistants and prevent them from becoming the factory's promoters
.
.
Chain pharmacies generally taboo that manufacturers directly reward the store manager and clerk.
Instead, they require manufacturers to return the rebates to the chain headquarters, which has its own set of internal incentive measures
.
This is to prevent some manufacturers' rebates from wooing their own shop assistants and prevent them from becoming the factory's promoters
.
The attitude reflected in the optimization of the content of this circulating version of the document is also to prevent certain risks from occurring.
Therefore, some pharmaceutical companies use the surplus reserve policy to accelerate the over-completed procurement of selected products , and may face some new changes
.
Therefore, some pharmaceutical companies use the surplus reserve policy to accelerate the over-completed procurement of selected products , and may face some new changes
.
In June last year, the National Medical Insurance Administration and the Ministry of Finance jointly issued the "Guiding Opinions on the Retention of Chinese Medical Insurance Funds for Centralized Drug Purchase by the State", which was formulated on the basis of three rounds and two batches of the National Mass Purchase (VBP) operation.
Supporting documents for medical insurance
.
Supporting documents for medical insurance
.
The core idea of the opinion is “reserve the balance”, that is, the difference between the drug cost after the VBP price reduction and the budget fund paid by the medical insurance will be returned as a part of the reward to the public medical institution, which will greatly stimulate the medical institution to give priority to using the selected product, and has an even more impact The future trend of non-selected varieties
.
.
Some provinces and cities have cashed out the remaining funds for medical insurance
Since then, various provinces and cities have successively issued documents to clarify the relevant policies for the retention of balances
.
So, as for the results of various medical institutions after implementation, we have also collected relevant data
.
.
So, as for the results of various medical institutions after implementation, we have also collected relevant data
.
On December 4, 2020, the Hunan Provincial Medical Insurance Bureau issued the "Implementation Opinions on the Retention of the Chinese Medical Insurance Funds in the Centralized Procurement of Drugs Organized by the State (for Trial Implementation)"
.
.
On January 15 this year, according to the "Chongqing Daily" report, a total of 157 medical institutions in Chongqing participated in the first batch of national centralized procurement of 25 selected drugs and medical insurance fund balance retention assessment, of which 102 medical institutions passed the assessment and the balance medical insurance fund was 61,974,400 Yuan
.
.
In December last year, according to a report by Great Wall.
com, the Hebei Provincial Medical Security Bureau and the Hebei Provincial Department of Finance passed a joint assessment and assessment, combined with the self-evaluation of the Hebei Provincial People’s Hospital and other 26 medical institutions participating in the first batch of centralized drug procurement, and allocated the balance.
More than 8.
47 million yuan was retained, and the payment was completed on November 5, 2020
.
com, the Hebei Provincial Medical Security Bureau and the Hebei Provincial Department of Finance passed a joint assessment and assessment, combined with the self-evaluation of the Hebei Provincial People’s Hospital and other 26 medical institutions participating in the first batch of centralized drug procurement, and allocated the balance.
More than 8.
47 million yuan was retained, and the payment was completed on November 5, 2020
.
According to the news from the "Xiamen Haixi Medical Trading Center" in November 2020, Haixi has helped many cities in Hebei Province, such as Handan, Hengshui, Xinji, Dingzhou, and Qinhuangdao, complete the calculation of remaining balances.
The amount of remaining funds that can be allocated to medical institutions exceeds hundreds of millions of yuan
.
The amount of remaining funds that can be allocated to medical institutions exceeds hundreds of millions of yuan
.
Among them, the calculation scope of Handan City's remaining balance is the first batch of 25 countries to purchase medicines, 370 medical institutions are reported in the city, and a total of 281 hospitals have generated remaining balances
.
According to preliminary calculations, the estimated base of the city's first batch of national organizations with drug balances is about 100 million yuan.
According to the largest balance retention ratio of 50%, the balance retained for return to medical institutions this time is about 51,816,800 yuan
.
.
According to preliminary calculations, the estimated base of the city's first batch of national organizations with drug balances is about 100 million yuan.
According to the largest balance retention ratio of 50%, the balance retained for return to medical institutions this time is about 51,816,800 yuan
.
The space for non-selected varieties is getting smaller and smaller, how should pharmaceutical companies respond?
Regarding the definition and calculation formula analysis of the medical insurance balance retention policy, we also wrote an article "The Outflow of Medical Insurance "Retention Balance" Policy, Analysis of 3 Core Indicators", which can be accessed by clicking the blue title
.
.
Among them, it is worth noting that although the relevant policy does not clearly state that the non-selected products are not allowed to be used, there is still room for it.
After all, the non-selected and the selected varieties are in the hospital drug catalog, and the use of the selected varieties has priority and evaluation indicators.
, Also retains the right to choose non-selected varieties
.
However, the right of choice is obviously not advantageous to priority, and its purpose is to force relevant pharmaceutical companies to actively participate in centralized procurement
.
After all, the non-selected and the selected varieties are in the hospital drug catalog, and the use of the selected varieties has priority and evaluation indicators.
, Also retains the right to choose non-selected varieties
.
However, the right of choice is obviously not advantageous to priority, and its purpose is to force relevant pharmaceutical companies to actively participate in centralized procurement
.
In addition, some experts analyzed that the amount of use of non-selected products will be accumulated in the retention of medical insurance balances, which reduces incentives.
It is very detrimental to products with excessive price reductions.
The purpose of this policy is to encourage accurate reporting of localities and encourage various Hospitals use as many selected products as possible
.
It is very detrimental to products with excessive price reductions.
The purpose of this policy is to encourage accurate reporting of localities and encourage various Hospitals use as many selected products as possible
.
It can be predicted that in the future, under the dual effects of the continuous lowering of drug prices with volume purchases and the retention of medical insurance balances, medical institutions will mainly adopt selected drugs , which indirectly suppresses the use of non-selected products.
For non-selected drugs, more and more room for survival The smaller the size, the related pharmaceutical companies will also be affected to a certain extent
.
For non-selected drugs, more and more room for survival The smaller the size, the related pharmaceutical companies will also be affected to a certain extent
.
Medical Network News, June 8th.
At present, the national centralized procurement has conducted four batches and five rounds.
As the results of the previous rounds of centralized procurement have been implemented in various places, the medical insurance supporting policies have been promulgated and implemented accordingly
.
Among them, the retention of medical insurance balances is also the focus of the industry
.
At present, the national centralized procurement has conducted four batches and five rounds.
As the results of the previous rounds of centralized procurement have been implemented in various places, the medical insurance supporting policies have been promulgated and implemented accordingly
.
Among them, the retention of medical insurance balances is also the focus of the industry
.
On June 4, the Guangxi Autonomous Region Medical Insurance Bureau and the Autonomous Region’s Department of Finance issued the "Implementation Opinions on the Retention of Chinese Medical Insurance Funds for the Centralized Purchase of Drugs by the State and the Autonomous Region
.
"
.
"
This opinion applies to all batches of centralized procurement drug varieties organized by the state, inter-provincial alliances, and autonomous regions
.
According to the agreed procurement volume and the selected price of the selected products of the centralized procurement agency, the amount of the non-selected products used, as well as the actual payment ratio of the medical insurance fund in the overall planning area and the proportion of the insured patients in the centralized procurement of generic drugs, the calculation of the centralized procurement agency The amount of medical insurance expenditures for generic drugs that are lower than the part of the medical insurance fund budget for centralized drugs is the base for calculating the balance
.
.
According to the agreed procurement volume and the selected price of the selected products of the centralized procurement agency, the amount of the non-selected products used, as well as the actual payment ratio of the medical insurance fund in the overall planning area and the proportion of the insured patients in the centralized procurement of generic drugs, the calculation of the centralized procurement agency The amount of medical insurance expenditures for generic drugs that are lower than the part of the medical insurance fund budget for centralized drugs is the base for calculating the balance
.
The opinion also pointed out that other medical procurement work in the whole district can refer to this implementation opinion and implement the retention of medical insurance funds
.
All centralized procurement agencies must do a good job in the smooth replacement of selected products, precise policy implementation, and no “one size fits all”
.
Medicine Medicine Medicine.
All centralized procurement agencies must do a good job in the smooth replacement of selected products, precise policy implementation, and no “one size fits all”
.
The policy of "Medical Reserve and Surplus Balance" has changed, and it must not be directly linked to departments and individuals!
The policy of "Medical Reserve and Surplus Balance" has changed, and it must not be directly linked to departments and individuals! Just in April this year, a "Notice on Strengthening the Management of the Use of the Balance of Medical Insurance Funds for the Centralized Procurement of Medicines and Consumables in the State Organization" was circulated in the industry
.
It pointed out that medical institutions should make good use of the increased disposable income by reducing the cost of medicines and consumables, implement the "two permits" requirements, actively promote the reform of the salary system, mobilize the enthusiasm of medical staff, and must not directly use the remaining funds for centralized procurement of medical insurance.
Departments and personal incentives are linked
.
.
It pointed out that medical institutions should make good use of the increased disposable income by reducing the cost of medicines and consumables, implement the "two permits" requirements, actively promote the reform of the salary system, mobilize the enthusiasm of medical staff, and must not directly use the remaining funds for centralized procurement of medical insurance.
Departments and personal incentives are linked
.
Note that some changes have taken place in the incentive methods and targets of surplus funds, and it has been clarified that surplus funds should not be linked to the use of departments and personal incentives
.
The precise description of the prohibited scope is obviously an optimization of the previous policy to prevent certain departments and individuals from prescribing random prescriptions in order to get bonus incentives
.
This provision is consistent with the "Nine Prohibitions"-the prohibition of linking the personal income of medical and health personnel with the income of medicines and medical examinations, and the prohibition of issuing commissions
.
.
The precise description of the prohibited scope is obviously an optimization of the previous policy to prevent certain departments and individuals from prescribing random prescriptions in order to get bonus incentives
.
This provision is consistent with the "Nine Prohibitions"-the prohibition of linking the personal income of medical and health personnel with the income of medicines and medical examinations, and the prohibition of issuing commissions
.
If you compare the above regulations with the chain pharmacy 's rebate policy for manufacturers, it is found that there is the same truth
.
Chain pharmacies generally taboo that manufacturers directly reward the store manager and clerk.
Instead, they require manufacturers to return the rebates to the chain headquarters, which has its own set of internal incentive measures
.
This is to prevent some manufacturers' rebates from wooing their own shop assistants and prevent them from becoming the factory's promoters
.
Pharmacy pharmacy pharmacy.
Chain pharmacies generally taboo that manufacturers directly reward the store manager and clerk.
Instead, they require manufacturers to return the rebates to the chain headquarters, which has its own set of internal incentive measures
.
This is to prevent some manufacturers' rebates from wooing their own shop assistants and prevent them from becoming the factory's promoters
.
The attitude reflected in the optimization of the content of this circulating version of the document is also to prevent certain risks from occurring.
Therefore, some pharmaceutical companies use the surplus reserve policy to accelerate the over-completed procurement of selected products , and may face some new changes
.
Procurement Procurement ProcurementTherefore, some pharmaceutical companies use the surplus reserve policy to accelerate the over-completed procurement of selected products , and may face some new changes
.
In June last year, the National Medical Insurance Administration and the Ministry of Finance jointly issued the "Guiding Opinions on the Retention of Chinese Medical Insurance Funds for Centralized Drug Purchase by the State", which was formulated on the basis of three rounds and two batches of the National Mass Purchase (VBP) operation.
Supporting documents for medical insurance
.
Supporting documents for medical insurance
.
The core idea of the opinion is “reserve the balance”, that is, the difference between the drug cost after the VBP price reduction and the budget fund paid by the medical insurance will be returned as a part of the reward to the public medical institution, which will greatly stimulate the medical institution to give priority to using the selected product, and has an even more impact The future trend of non-selected varieties
.
.
Some provinces and cities have cashed out the remaining funds for medical insurance
Some provinces and cities have cashed out the remaining funds for medical insurance Since then, various provinces and cities have successively issued documents to clarify the relevant policies for the retention of balances
.
So, as for the results of various medical institutions after implementation, we have also collected relevant data
.
.
So, as for the results of various medical institutions after implementation, we have also collected relevant data
.
On December 4, 2020, the Hunan Provincial Medical Insurance Bureau issued the "Implementation Opinions on the Retention of the Chinese Medical Insurance Funds in the Centralized Procurement of Drugs Organized by the State (for Trial Implementation)"
.
.
On January 15 this year, according to the "Chongqing Daily" report, a total of 157 medical institutions in Chongqing participated in the first batch of national centralized procurement of 25 selected drugs and medical insurance fund balance retention assessment, of which 102 medical institutions passed the assessment and the balance medical insurance fund was 61,974,400 Yuan
.
.
In December last year, according to a report by Great Wall.
com, the Hebei Provincial Medical Security Bureau and the Hebei Provincial Department of Finance passed a joint assessment and assessment, combined with the self-evaluation of the Hebei Provincial People’s Hospital and other 26 medical institutions participating in the first batch of centralized drug procurement, and allocated the balance.
More than 8.
47 million yuan was retained, and the payment was completed on November 5, 2020
.
Hospital hospital hospitalcom, the Hebei Provincial Medical Security Bureau and the Hebei Provincial Department of Finance passed a joint assessment and assessment, combined with the self-evaluation of the Hebei Provincial People’s Hospital and other 26 medical institutions participating in the first batch of centralized drug procurement, and allocated the balance.
More than 8.
47 million yuan was retained, and the payment was completed on November 5, 2020
.
According to the news from the "Xiamen Haixi Medical Trading Center" in November 2020, Haixi has helped many cities in Hebei Province, such as Handan, Hengshui, Xinji, Dingzhou, and Qinhuangdao, complete the calculation of remaining balances.
The amount of remaining funds that can be allocated to medical institutions exceeds hundreds of millions of yuan
.
The amount of remaining funds that can be allocated to medical institutions exceeds hundreds of millions of yuan
.
Among them, the calculation scope of Handan City's remaining balance is the first batch of 25 countries to purchase medicines, 370 medical institutions are reported in the city, and a total of 281 hospitals have generated remaining balances
.
According to preliminary calculations, the estimated base of the city's first batch of national organizations with drug balances is about 100 million yuan.
According to the largest balance retention ratio of 50%, the balance retained for return to medical institutions this time is about 51,816,800 yuan
.
.
According to preliminary calculations, the estimated base of the city's first batch of national organizations with drug balances is about 100 million yuan.
According to the largest balance retention ratio of 50%, the balance retained for return to medical institutions this time is about 51,816,800 yuan
.
The space for non-selected varieties is getting smaller and smaller, how should pharmaceutical companies respond?
Regarding the definition and calculation formula analysis of the medical insurance balance retention policy, we also wrote an article "The Outflow of Medical Insurance "Retention Balance" Policy, Analysis of 3 Core Indicators", which can be accessed by clicking the blue title
.
.
Among them, it is worth noting that although the relevant policy does not clearly state that the non-selected products are not allowed to be used, there is still room for it.
After all, the non-selected and the selected varieties are in the hospital drug catalog, and the use of the selected varieties has priority and evaluation indicators.
, Also retains the right to choose non-selected varieties
.
However, the right of choice is obviously not advantageous to priority, and its purpose is to force relevant pharmaceutical companies to actively participate in centralized procurement
.
After all, the non-selected and the selected varieties are in the hospital drug catalog, and the use of the selected varieties has priority and evaluation indicators.
, Also retains the right to choose non-selected varieties
.
However, the right of choice is obviously not advantageous to priority, and its purpose is to force relevant pharmaceutical companies to actively participate in centralized procurement
.
In addition, some experts analyzed that the amount of use of non-selected products will be accumulated in the retention of medical insurance balances, which reduces incentives.
It is very detrimental to products with excessive price reductions.
The purpose of this policy is to encourage accurate reporting of localities and encourage various Hospitals use as many selected products as possible
.
It is very detrimental to products with excessive price reductions.
The purpose of this policy is to encourage accurate reporting of localities and encourage various Hospitals use as many selected products as possible
.
It can be predicted that in the future, under the dual effects of the continuous lowering of drug prices with volume purchases and the retention of medical insurance balances, medical institutions will mainly adopt selected drugs , which indirectly suppresses the use of non-selected products.
For non-selected drugs, more and more room for survival The smaller the size, the related pharmaceutical companies will also be affected to a certain extent
.
Medicine, medicine, medicine For non-selected drugs, more and more room for survival The smaller the size, the related pharmaceutical companies will also be affected to a certain extent
.
